ConductScience.org, home

Paper40587482

The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.

Kong D and 8 others. PLoS One, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance. Papers, record 40587482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40587482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.
PubMed
Journal
PLoS One
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-23
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kong DDehuahttps://orcid.org/0009-0003-4899-0808
2Gao CChunyan
3Yu YYang
4Yang LLu
5Ma JJi
6Tang SShimin
7Mao YYing
8Li YYong
9Li NNahttps://orcid.org/0000-0002-5504-4874

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Programmed Cell Death 1 ReceptorMajor topic
Esophageal NeoplasmsMajor topic
Humans
Female
Male
Prognosis
Middle Aged
Aged
Forkhead Transcription Factors
B7-H1 Antigen
Interleukin-2 Receptor alpha Subunit
Biomarkers, Tumor
Lymphatic Metastasis
Kaplan-Meier Estimate
Adult
Lymphocytes, Tumor-Infiltrating

Source PubMed

Download CSV of topics

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133302322Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy.Eur J Immunol2021https://conductscience.org/library/papers/33302322PubMed
226718132Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8⁺ T cells.Oncol Rep2016https://conductscience.org/library/papers/26718132PubMed
337907738CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential.Exp Mol Med2023https://conductscience.org/library/papers/37907738PubMed
436159781Roles of CD4+ T cells as mediators of antitumor immunity.Front Immunol2022https://conductscience.org/library/papers/36159781PubMed
536480211Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1 Subgroups.JAMA Oncol2023https://conductscience.org/library/papers/36480211PubMed
630888929PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations.Hum Vaccin Immunother2019https://conductscience.org/library/papers/30888929PubMed
737820583CD8+ T cells in the cancer-immunity cycle.Immunity2023https://conductscience.org/library/papers/37820583PubMed
824751582The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis.Am J Gastroenterol2014https://conductscience.org/library/papers/24751582PubMed
932965635Epidemiology of esophageal cancer: update in global trends, etiology and risk factors.Clin J Gastroenterol2020https://conductscience.org/library/papers/32965635PubMed
1030296523PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma.Hum Pathol2019https://conductscience.org/library/papers/30296523PubMed
1137668710PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.Cancer Immunol Immunother2023https://conductscience.org/library/papers/37668710PubMed
1230551854Risk factors for oesophageal cancer.Best Pract Res Clin Gastroenterol2018https://conductscience.org/library/papers/30551854PubMed
1336082452CD25: A potential tumor therapeutic target.Int J Cancer2023https://conductscience.org/library/papers/36082452PubMed
1435771261Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/35771261PubMed
1530713780IL-33 increases ST2+ Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner.Oncoimmunology2019https://conductscience.org/library/papers/30713780PubMed
1638572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1733725774A low proportion of regulatory T cells before chemoradiotherapy predicts better overall survival in esophageal cancer.Ann Palliat Med2021https://conductscience.org/library/papers/33725774PubMed
1834307133FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1.Front Oncol2021https://conductscience.org/library/papers/34307133PubMed
1925638546Anti-PD-L1 antibody active in metastatic bladder cancer.Lancet Oncol2015https://conductscience.org/library/papers/25638546PubMed
2037812328Esophageal Cancer: Overview, Risk Factors, and Reasons for the Rise.Curr Gastroenterol Rep2023https://conductscience.org/library/papers/37812328PubMed

See all 63 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41089601Multicenter validation of CEACAM6 and FOXP3 as robust prognostic biomarkers in colon cancer: Combined immunohistochemical and transcriptomic analysis.Mol Clin Oncol2025https://conductscience.org/library/papers/41089601

Source PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40587482

GET https://conductscience.org/api/papers/v1/40587482/references?page=2